Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22431716 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna
Conditions: Cancer;   Lentigo Maligna
Interventions: Drug: Imiquimod Cream;   Drug: Tazarotene Cream 0.1%

Study has passed its completion date and status has not been verified in more than two years.